170 related articles for article (PubMed ID: 14636273)
1. Bone marrow histopathology following cytoreductive therapy in chronic idiopathic myelofibrosis.
Thiele J; Kvasnicka HM; Schmitt-Graeff A; Diehl V
Histopathology; 2003 Nov; 43(5):470-9. PubMed ID: 14636273
[TBL] [Abstract][Full Text] [Related]
2. Therapy-related changes of the bone marrow in chronic idiopathic myelofibrosis.
Thiele J; Kvasnicka HM; Schmitt-Gräff A; Hülsemann R; Diehl V
Histol Histopathol; 2004 Jan; 19(1):239-50. PubMed ID: 14702192
[TBL] [Abstract][Full Text] [Related]
3. Effects of chemotherapy (busulfan-hydroxyurea) and interferon-alfa on bone marrow morphologic features in chronic myelogenous leukemia. Histochemical and morphometric study on sequential trephine biopsy specimens with special emphasis on dynamic features.
Thiele J; Kvasnicka HM; Schmitt-Graeff A; Bundschuh S; Biermann T; Roessler G; Wasmus M; Diehl V; Zankovich R; Schaefer HE
Am J Clin Pathol; 2000 Jul; 114(1):57-65. PubMed ID: 10884800
[TBL] [Abstract][Full Text] [Related]
4. Dynamics of fibrosis in chronic idiopathic (primary) myelofibrosis during therapy: a follow-up study on 309 patients.
Thiele J; Kvasnicka HM; Schmitt-Graeff A; Diehl V
Leuk Lymphoma; 2003 Jun; 44(6):949-53. PubMed ID: 12854892
[TBL] [Abstract][Full Text] [Related]
5. The impact of interferon versus busulfan therapy on the reticulin stain-measured fibrosis in CML--a comparative morphometric study on sequential trephine biopsies.
Thiele J; Kvasnicka HM; Niederle N; Zirbes TK; Schmidt M; Dammasch J; Meuter BR; Leder LD; Kloke O; Diehl V
Ann Hematol; 1995 Mar; 70(3):121-8. PubMed ID: 7536475
[TBL] [Abstract][Full Text] [Related]
6. Changing patterns of histological subgroups during therapy of Ph1+ chronic myelogenous leukaemia.
Thiele J; Kvasnicka HM; Schmitt-Graeff A; Leder LD; Schaefer HE
Histopathology; 2000 Oct; 37(4):355-62. PubMed ID: 11012743
[TBL] [Abstract][Full Text] [Related]
7. Evolution of myelofibrosis in chronic idiopathic myelofibrosis as evidenced in sequential bone marrow biopsy specimens.
Buhr T; Büsche G; Choritz H; Länger F; Kreipe H
Am J Clin Pathol; 2003 Jan; 119(1):152-8. PubMed ID: 12520711
[TBL] [Abstract][Full Text] [Related]
8. Early-stage idiopathic (primary) myelofibrosis--current issues of diagnostic features.
Thiele J; Kvasnicka HM; Zankovich R; Diehl V
Leuk Lymphoma; 2002 May; 43(5):1035-41. PubMed ID: 12148883
[TBL] [Abstract][Full Text] [Related]
9. [Successful treatment of primary myelofibrosis by busulfan pulse therapy: report of a case].
Uemura Y; Iwahara Y; Kataoka R; Muneishi H; Miyoshi I
Rinsho Ketsueki; 1990 Sep; 31(9):1553-6. PubMed ID: 2246832
[TBL] [Abstract][Full Text] [Related]
10. Clinical and morphological criteria for the diagnosis of prefibrotic idiopathic (primary) myelofibrosis.
Thiele J; Kvasnicka HM; Zankovich R; Diehl V
Ann Hematol; 2001 Mar; 80(3):160-5. PubMed ID: 11320901
[TBL] [Abstract][Full Text] [Related]
11. Initial (prefibrotic) stages of idiopathic (primary) myelofibrosis (IMF) - a clinicopathological study.
Thiele J; Kvasnicka HM; Boeltken B; Zankovich R; Diehl V; Fischer R
Leukemia; 1999 Nov; 13(11):1741-8. PubMed ID: 10557047
[TBL] [Abstract][Full Text] [Related]
12. Remission of chronic idiopathic myelofibrosis to busulfan treatment.
Chang JC; Gross HM
Am J Med Sci; 1988 May; 295(5):472-6. PubMed ID: 3376991
[TBL] [Abstract][Full Text] [Related]
13. Therapy-related changes of CD34+ progenitor cells in chronic myeloid leukemia: a morphometric study on sequential trephine biopsies.
Thiele J; Kvasnicka HM; Schmitt-Graeff A; Goekce D; Diehl V; Zankovich R; Schaefer HE
J Hematother Stem Cell Res; 2001 Dec; 10(6):827-36. PubMed ID: 11798509
[TBL] [Abstract][Full Text] [Related]
14. Relevance of bone marrow features in the differential diagnosis between essential thrombocythemia and early stage idiopathic myelofibrosis.
Thiele J; Kvasnicka HM; Zankovich R; Diehl V
Haematologica; 2000 Nov; 85(11):1126-34. PubMed ID: 11064463
[TBL] [Abstract][Full Text] [Related]
15. Effects of interferon and hydroxyurea on bone marrow fibrosis in chronic myelogenous leukaemia: a comparative retrospective multicentre histological and clinical study.
Thiele J; Kvasnicka HM; Schmitt-Graeff A; Spohr M; Diehl V; Zankovich R; Niederle N; Leder LD
Br J Haematol; 2000 Jan; 108(1):64-71. PubMed ID: 10651725
[TBL] [Abstract][Full Text] [Related]
16. Reversal of myelofibrosis by hydroxyurea.
Löfvenberg E; Wahlin A; Roos G; Ost A
Eur J Haematol; 1990 Jan; 44(1):33-8. PubMed ID: 2307218
[TBL] [Abstract][Full Text] [Related]
17. [Improvement of bone marrow hematopoiesis in idiopathic myelofibrosis with prednisolone].
Tanosaki R; Uchida H; Masuda Y; Michikawa N; Ogawa T; Kubo A; Ikeda Y
Rinsho Ketsueki; 1992 Feb; 33(2):256-8. PubMed ID: 1635179
[TBL] [Abstract][Full Text] [Related]
18. A sequential histological study of bone marrow fibrosis in idiopathic myelofibrosis.
Hasselbalch H; Lisse I
Eur J Haematol; 1991 May; 46(5):285-9. PubMed ID: 2044723
[TBL] [Abstract][Full Text] [Related]
19. CD34+ stem cells in chronic myeloproliferative disorders.
Thiele J; Kvasnicka HM
Histol Histopathol; 2002 Apr; 17(2):507-21. PubMed ID: 11962756
[TBL] [Abstract][Full Text] [Related]
20. Therapy-related changes of CD20+ and CD45RO+ lymphocyte subsets in chronic myeloid leukemia (CML): an immunohistochemical and morphometric study on sequential trephine biopsies of the bone marrow.
Thiele J; Kvasnicka HM; Schmitt-Graeff A; Cvetanovska G; Blum N; Schaefer HE
Mod Pathol; 2000 Aug; 13(8):888-96. PubMed ID: 10955456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]